CNS Pharmaceuticals, Inc. (CNSP)

NASDAQ: CNSP · Real-Time Price · USD

1.260

+0.110 (9.57%)

At close: May 15, 2025, 4:00 PM

1.150

-0.110 (-8.73%)

After-hours: May 15, 2025, 7:59 PM EDT

CNS Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Selling, General & Admin	5.61	4.77	5.97	4.68	4.39	Upgrade
Research & Development	9.29	14.1	9.3	9.81	5.06	Upgrade
Operating Expenses	14.9	18.87	15.27	14.49	9.45	Upgrade
Operating Income	-14.9	-18.87	-15.27	-14.49	-9.45	Upgrade
Interest Expense	-0.02	-0.01	-0.01	-0.01	-0	Upgrade
Interest & Investment Income	0.06	0.03	-	-	-	Upgrade
EBT Excluding Unusual Items	-14.86	-18.85	-15.27	-14.5	-9.46	Upgrade
Pretax Income	-14.86	-18.85	-15.27	-14.5	-9.46	Upgrade
Net Income	-14.86	-18.85	-15.27	-14.5	-9.46	Upgrade
Net Income to Common	-14.86	-18.85	-15.27	-14.5	-9.46	Upgrade
Shares Outstanding (Basic)	0	-	-	-	-	Upgrade
Shares Outstanding (Diluted)	0	-	-	-	-	Upgrade
EPS (Basic)	-38.87	-	-	-	-	Upgrade
EPS (Diluted)	-38.87	-	-	-	-	Upgrade
Free Cash Flow	-17.12	-14.14	-10.56	-13.54	-7.34	Upgrade
Free Cash Flow Per Share	-44.78	-	-	-	-	Upgrade
EBITDA	-14.9	-18.86	-15.26	-14.47	-9.44	Upgrade
D&A For EBITDA	0	0	0.01	0.01	0.01	Upgrade
EBIT	-14.9	-18.87	-15.27	-14.49	-9.45	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q